X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

SCANDINAVIAN JOURNAL OF IMMUNOLOGY

期刊標題檢索 SCAND J IMMUNOL 最新評論: It has been three days since I submitted my work, why haven't I recei... (2024-04-08)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[SCANDINAVIAN JOURNAL OF IMMUNOLOGY]您好,您是該頁面的第 25826 位訪客。

期刊簡介
期刊名稱SCANDINAVIAN JOURNAL OF IMMUNOLOGY SCANDINAVIAN JOURNAL OF IMMUNOLOGY
LetPub Score
6.3
50 ratings
Rate

Reputation
7.6

Influence
5.1

Speed
7.0

期刊簡稱SCAND J IMMUNOL
ISSN0300-9475
E-ISSN1365-3083
h-index82
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.700.9460.799
Subject fieldQuartilesRankPercentile
Category: Immunology and Microbiology
Subcategory: Immunology
Q284 / 236

自引率 (2023-2024)2.40%自引率趨勢
掲載範囲
This peer-reviewed international journal publishes original articles and reviews on all aspects of basic, translational and clinical immunology. The journal aims to provide high quality service to authors, and high quality articles for readers.

The journal accepts for publication material from investigators all over the world, which makes a significant contribution to basic, translational and clinical immunology.
官方網站http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-3083
在線稿件提交https://mc.manuscriptcentral.com/sji
開放訪問No
出版商Wiley-Blackwell Publishing Ltd
主題領域医学
出版國/地區NORWAY
發行頻率月刊
創刊年1972
每年文章數78每年文章數趨勢
黃金OA百分比23.61%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ274/181
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0300-9475%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1.5 Month(s)
競爭力 *來自作者的數據: About 95%
參考鏈接
相關期刊 【SCANDINAVIAN JOURNAL OF IMMUNOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 40.00
    Annual Review of ImmunologyH-index: 279

    CiteScore: 57.20
    ImmunityH-index: 355

    CiteScore: 49.40
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 31.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 25.10
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 26.60
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 24.70
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 29.60
    JOURNAL OF AUTOIMMUNITYH-index: 101

    CiteScore: 27.90
    學科內最受檢索的期刊 頁面查看次數
    International Immunopharmacology316287
    JOURNAL OF IMMUNOLOGY156690
    Immunity107934
    Cellular & Molecular Immunology107432
    Vaccine104772
    JOURNAL OF EXPERIMENTAL MEDICINE99452
    MICROBIAL PATHOGENESIS94242
    MOLECULAR IMMUNOLOGY91041
    INFLAMMATION89741
    BRAIN BEHAVIOR AND IMMUNITY84724
  •  

    SCANDINAVIAN JOURNAL OF IMMUNOLOGY SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [SCANDINAVIAN JOURNAL OF IMMUNOLOGY] 的評論撰寫評論
作者: 鲍德温伯恩斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-08 11:59:18 評論於
It has been three days since I submitted my work, why haven't I received a submission number yet? How many days does it usually take for you to assign submission numbers?
(0) 讚! | 鲍德温伯恩斯

作者: 鲍德温伯恩斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-07 20:16:32 評論於
How long does it usually take for the first trial?
(0) 讚! | 鲍德温伯恩斯

作者: 鲍德温伯恩斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-07 20:05:44 評論於
How long does the first instance usually take?
(0) 讚! | 鲍德温伯恩斯

作者: Hubery Ackermann


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-28 19:15:09 評論於
How is it going?
(0) 讚! | Hubery Ackermann

作者: Hubery Ackermann


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-28 12:59:44 評論於
Can't understand bioinformatics
(0) 讚! | Hubery Ackermann

作者: Anxin_


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2022-11-03 22:59:01 評論於
2022-05-08 submission;
2022-05-25 no response to the reminder;
2022-06-18 considering withdrawing the submission, the editor replied with a good email persuading to stay;
2022-07-05 received feedback for revisions from two reviewers;
2022-09-14 submitted the revised manuscript;
2022-10-17 accepted.
The reviewers asked very professional and detailed questions, ranging from grammar errors to improvements in research methods. Thank you very much for accepting the article!
(0) 讚! | Anxin_

作者: 极乐翠翠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-25 23:13:31 評論於
Review speed: 3.0 | Submission success rate: 50.0
Experience sharing: Pretty good, it's my debut work
(0) 讚! | 极乐翠翠

作者: Caesar Ingersoll


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-23 11:34:51 評論於
How did it end? Did you win?
(0) 讚! | Caesar Ingersoll

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:57:28 評論於
The number of corresponding authors for SCI journal papers is not necessarily limited to one, and there is no fixed standard for how many there should be. This is because different SCI journals have different policies regarding corresponding authors. For SCI journals that only accept one corresponding author, if a paper has multiple corresponding authors, the first corresponding author will be automatically selected as the corresponding author. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. The same applies to other requirements; the number of corresponding authors listed by the authors should comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contributions to the experiment and writing of the paper, typically the person whose name appears first in the author list. However, in collaborations involving multiple authors, it is common to have co-first authors. There is no specific rule on the number of co-first authors, which largely depends on the workload, length of the paper, publication guidelines, and recognition by the institution. In general, having 2-4 first authors for an SCI paper is most common
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:04:45 評論於
Yes
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 18:58:43 評論於
How many corresponding authors/first authors can a journal have?
(0) 讚! | 龙鳞孝礼

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 16:20:28 評論於
Do all authors receive an email after the article is accepted?
(0) 讚! | 平原文波

作者: 佛光善芳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-07 16:39:53 評論於
Where can I find the LaTeX template, please? Thank you
(0) 讚! | 佛光善芳

作者: 佛光善芳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-07 10:27:28 評論於
Where can I find the LaTeX template? Thank you
(0) 讚! | 佛光善芳

作者: 云来骞信


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-13 17:52:54 評論於
Hello! How long does it take for your submission with the status of "awaiting AE assignment" to be rejected?
(0) 讚! | 云来骞信

作者: Constance Frank


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-08-10 20:24:43 評論於
Rejected, the manuscript has been submitted to another journal for consideration
(0) 讚! | Constance Frank

作者: 书生俊娥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-21 17:35:16 評論於
Review speed: 2.0 | Submission success rate: 50.0 
Experience sharing: The first review took 1.5 months, followed by major revisions and acceptance, taking a total of 5 months
(0) 讚! | 书生俊娥

作者: 重阳永元


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-18 19:03:36 評論於
What is your current status?
(0) 讚! | 重阳永元

作者: 重阳永元


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-18 12:51:55 評論於
What is the status now? Has it been reviewed? I have been waiting for over a month and it hasn't been reviewed yet, why is it so slow?
(0) 讚! | 重阳永元

作者: 重阳永元


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-16 17:00:33 評論於
It has been over a month since I submitted the manuscript, but the review process has not started yet. What is going on?
(0) 讚! | 重阳永元

作者: Constance Frank


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-04-22 21:39:06 評論於
How long does it take for awaiting AE assignment?
(0) 讚! | Constance Frank

作者: 明冠庚子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-04-06 22:52:37 評論於
Sorry, when did you submit? I submitted on February 22 and haven't received any feedback yet, still awaiting reviewer assignment
(0) 讚! | 明冠庚子

作者: 玉霄玉怡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-25 11:59:32 評論於
Review Speed: 3.0 | Submission Acceptance Rate: 75.0
Experience Sharing: Submitted in July 2019, revised in November, first review took nearly 4 months, with 2 major revisions and 1 minor revision. Accepted on March 24, 2020, taking a total of 8 months, the first review was not fast
(0) 讚! | 玉霄玉怡

作者: 明冠庚子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-02-21 23:40:51 評論於
There are two options, if you do not choose gold OA, there will be no page fee.                                                                                                                 
Anonymous   Published on  Jan. 4, 2017::SCI(2015):2.27 SCI(2014):1.739 Is the page fee expensive? How much is it?
(0) 讚! | 明冠庚子

作者: Maurice Woolf


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-02-21 19:35:52 評論於
Review speed: 2.0 | Submission hit rate: 50.0
Experience sharing: 1.5 months for the first review, 3 weeks for the second review, took more than 3 months to accept
(0) 讚! | Maurice Woolf

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [SCANDINAVIAN JOURNAL OF IMMUNOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*